Exenatide and Dapagliflozin Combination Enhances Sertoli Cell Secretion of Key Metabolites for Spermatogenesis

The incidence of metabolic diseases such as type 2 diabetes mellitus (DM) and obesity has been increasing dramatically. Both diseases are closely linked and new approaches for type 2 DM treatment aim to enable weight loss. A combined therapy of dapagliflozin and exenatide has been used against type...

Full description

Bibliographic Details
Main Author: Ribeiro, João C. (author)
Other Authors: Martins, Ana D. (author), Jarak, Ivana (author), Carvalho, Rui A. (author), Alves, Marco G. (author), Oliveira, Pedro F. (author)
Format: article
Language:eng
Published: 2022
Subjects:
diabetes mellitus
Sertoli cells
dapagliflozin
exenatide
spermatogenesis
Online Access:http://hdl.handle.net/10316/103189
Country:Portugal
Oai:oai:estudogeral.sib.uc.pt:10316/103189

Internet

http://hdl.handle.net/10316/103189

Similar Items